calendar
7,900 catalysts · 5,256 phase readout · 2,298 8k filing · 343 pdufa · 255 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
7,900 catalysts · 5,256 phase readout · 2,298 8k filing · 343 pdufa · 255 earnings · 2 approval · 1 adcom
Sponsor: Hoffmann-La Roche. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Sponsor: Christian Candrian. Phase: NA. Conditions: Femoral Fracture
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Knee Osteoarthritis
Sponsor: Nordsjaellands Hospital. Phase: NA. Conditions: Primary Condition: Nerve Block, Secondary Condition: Catheter Displacement, Focus of Study: Sciatic Nerve
Sponsor: Duke University. Phase: NA. Conditions: Isolated Focal Hand Dystonia
Sponsor: Ain Shams University. Phase: PHASE3. Conditions: PreDiabetes
Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Urolithiasis
Sponsor: Suven Life Sciences Limited. Phase: PHASE3. Conditions: Agitation, Alzheimer's Type Dementia
Sponsor: Thomas Jefferson University. Phase: . Conditions: Prostate Carcinoma
Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Brown Adipose Tissue (BAT) Physiology, Cold Exposure
Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Osteoarthritis (OA) of the Knee
Sponsor: Chinese University of Hong Kong. Phase: PHASE2. Conditions: HCC
Sponsor: Medical University of Bialystok. Phase: NA. Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Sponsor: Vanderbilt University Medical Center. Phase: PHASE1. Conditions: Orthostatic Hypotension, Pure Autonomic Failure, Multiple System Atrophy, Autonomic Failure
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD. Phase: PHASE1. Conditions: Hepatic Impairment and Healthy Female
Sponsor: Ipsen. Phase: PHASE3. Conditions: Episodic Migraine
Sponsor: University of Health Sciences Lahore. Phase: NA. Conditions: Text Neck Syndrome
Sponsor: Fudan University. Phase: NA. Conditions: Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer
Sponsor: Hoffmann-La Roche. Phase: PHASE4. Conditions: Multiple Sclerosis, Clinically Isolated Syndrome
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Connective Tissue Disorders, Osteogenesis Imperfecta, Bone Diseases, Metabolic, Melorheostosis
Sponsor: National Institute of Mental Health (NIMH). Phase: PHASE1. Conditions: Long COVID, Post Acute Sequelae of COVID-19
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Spinal Cord Neoplasm
Sponsor: Samsun University. Phase: NA. Conditions: Acute Pain, Spinal Stenosis
Sponsor: Takeda. Phase: PHASE1. Conditions: Malignant Solid Tumors
Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Dental Anxiety in Children, Pediatric Anxiety
Sponsor: University of Oviedo. Phase: . Conditions: Hypothyroidism Primary
Sponsor: Pfizer. Phase: . Conditions: Acute Lymphocytic Leukemia
Sponsor: LanZhou University. Phase: NA. Conditions: Colonoscopy, Bowel Preparation, Quality of Healthcare
Sponsor: Tri-Service General Hospital (TSGH). Phase: NA. Conditions: Sleep Wake Disorders
Sponsor: Universidad Complutense de Madrid. Phase: NA. Conditions: Partial Edentulism, Tooth Loss / Rehabilitation
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Head and Neck Cancer
Sponsor: Bayer. Phase: PHASE2. Conditions: Metastatic Hormone-sensitive Prostate Cancer
Sponsor: Shanghai AbelZeta Ltd.. Phase: PHASE1. Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Sponsor: BRADEN DULONG. Phase: NA. Conditions: Platelet Dysfunction, Cardiopulmonary Bypass
Sponsor: IVIEW Therapeutics Inc.. Phase: PHASE2. Conditions: Dry Eye
Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Alcohol Use Disorder, Alcohol Abuse, Alcohol Dependence, Craving
Sponsor: Incyte Corporation. Phase: PHASE2. Conditions: Cutaneous Squamous Cell Carcinoma
Sponsor: King Saud University. Phase: NA. Conditions: Obesity (Disorder), Morbid Obesity, Bariatric Sleeve Gastrectomy, Meal Time, Chronotype, Circadian Rhythm
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Breast Cancer
Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Cancer
Sponsor: Almirall, S.A.. Phase: PHASE2. Conditions: Alopecia Areata
Sponsor: Boston Scientific Corporation. Phase: . Conditions: Parkinson Disease, Essential Tremor, Dystonia
Sponsor: University of Warmia and Mazury in Olsztyn. Phase: NA. Conditions: Inguinal Hernia Repair, Postoperative Pain, TAP Block
Sponsor: National Jewish Health. Phase: . Conditions: Cystic Fibrosis
Sponsor: Dr. Mark Mulder. Phase: . Conditions: Cancer-related Pain, Pain Assessment, Artificial Intelligence (AI), Oncology, Oncology Pain, Database, Facial Expression, Voice, Cancer
Sponsor: GlaxoSmithKline. Phase: PHASE4. Conditions: Meningitis, Meningococcal
Sponsor: xCures. Phase: . Conditions: Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer, Melanoma, Non Small Cell Lung Cancer, Thyroid Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Esophageal Cancer, Cholangiocarcinoma, Ovarian Cancer, Hepatocellular Carcinoma, Glioblastoma, MAPK Gene Mutation, KRAS Activating Mutation, BRAF Gene Mutation, NRAS Gene Mutation, HRAS Gene Mutation, MEK Mutation, ERK Mutation
Sponsor: Sun Yat-sen University. Phase: PHASE2. Conditions: Cancer Therapy-induced Thrombocytopenia (CTIT)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Phase: . Conditions: Velopharyngeal Insufficiency, Swallowing, Nasality, Speech